BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 6658120)

  • 21. [The content of cholylglycine in the blood serum in cholelithiasis during treatment with litholytic preparations of bile acids].
    Bocharova LV; Genia LP; Lemeshko ZA; Petrova EA
    Lab Delo; 1989; (3):59-61. PubMed ID: 2469846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cheno and urso compared and contrasted.
    Dowling RH
    Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
    Bateson MC; Hill A; Bouchier IA
    Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
    Whiting MJ; Watts JM
    Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
    [No Abstract]   [Full Text] [Related]  

  • 28. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Protein and pigment metabolism in the liver of patients with gallstones before and after treatment with cheno- and ursodeoxycholic acid preparations].
    Grebenev AL; Palinkashin DG; Genia LP; Golochevskaia VS; Lemeshko ZA
    Klin Med (Mosk); 1988 Mar; 66(3):96-9. PubMed ID: 3392933
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholelithiasis treated with chenodeoxycholic acid. An analysis of changes in the pattern of bile acids (author's transl)].
    Hrabák P; Dosková M; Soucková E
    Cas Lek Cesk; 1981 Jul; 120(27):817-23. PubMed ID: 7261002
    [No Abstract]   [Full Text] [Related]  

  • 32. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
    Bazzoli F; Fromm H; Roda A; Tunuguntla AK; Roda E; Barbara L; Amin P
    Dig Dis Sci; 1985 Jul; 30(7):650-4. PubMed ID: 4006647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endoscopic treatments. Etiopathogenesis and medical treatment of cholesterol lithiasis].
    Pirotte J
    Rev Med Liege; 1988 May; 43(9):365-9. PubMed ID: 3291050
    [No Abstract]   [Full Text] [Related]  

  • 34. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. Supplementary (1) Changes of bile acid metabolism by administration of chenodeoxycholic acid and ursodeoxycholic acid (author's transl)].
    Nakagawa S; Makino I
    Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1206-8. PubMed ID: 591760
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
    Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
    [No Abstract]   [Full Text] [Related]  

  • 36. Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.
    Bateson MC; Ross PE; Murison J; Saunders JH; Bouchier IA
    Gut; 1980 Apr; 21(4):305-10. PubMed ID: 7429292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dissolving biliary calculi: reality or myth?].
    Tor J
    Med Clin (Barc); 1983 Apr; 80(11):496-8. PubMed ID: 6865526
    [No Abstract]   [Full Text] [Related]  

  • 38. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. (6) Basic and clinical studies on bile acid preparations for the treatment of gallstones (author's transl)].
    Kajiyama G; Maruhashi A
    Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1201-5. PubMed ID: 591759
    [No Abstract]   [Full Text] [Related]  

  • 39. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 40. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.